ROBO Global^®

Healthcare Technology and Innovation ETF

Schedule of Investments

January 31, 2022 (Unaudited) 

Description	Shares		Fair Value
COMMON STOCK — 100.0%
Australia — 1.0%
Health Care — 1.0%
CSL		9,967	$	1,828,237
Total Australia				1,828,237
Belgium — 0.8%
Information Technology — 0.8%
Materialise ADR *		73,136		1,500,019
Total Belgium				1,500,019
China — 1.3%
Health Care — 1.3%
Ping An Healthcare and Technology *		764,300		2,421,044
Total China				2,421,044
Denmark — 1.0%
Health Care — 1.0%
GN Store Nord		29,553		1,770,339
Total Denmark				1,770,339
France — 2.1%
Health Care — 2.1%
Cellectis ADR *		336,812		2,091,603
Eurofins Scientific		18,175		1,808,617
Total Health Care				3,900,220
Total France				3,900,220
Germany — 1.3%
Health Care — 1.3%
Siemens Healthineers		37,038		2,356,654
Total Germany				2,356,654
Hong Kong — 2.1%
Consumer Discretionary — 1.1%
JD Health International *		258,050		2,063,394
Health Care — 1.0%
Alibaba Health Information Technology *		2,382,000		1,780,952
Total Hong Kong				3,844,346
Italy — 1.1%
Health Care — 1.1%
DiaSorin		13,370		2,051,827
Total Italy				2,051,827

Description	Shares		Fair Value
Japan — 0.7%
Health Care — 0.7%
Terumo		35,400	$	1,277,442
Total Japan				1,277,442
Netherlands — 1.2%
Health Care — 1.2%
Koninklijke Philips		69,262		2,281,532
Total Netherlands				2,281,532
Spain — 1.1%
Health Care — 1.1%
Grifols		112,095		1,961,531
Total Spain				1,961,531
Switzerland — 3.5%
Health Care — 3.5%
Lonza Group		3,119		2,121,878
Roche Holding		5,611		2,150,868
Tecan Group		4,340		2,087,377
Total Health Care				6,360,123
Total Switzerland				6,360,123
United Kingdom — 1.9%
Health Care — 1.9%
EMIS Group		85,538		1,505,680
Smith & Nephew PLC		118,623		1,994,954
Total Health Care				3,500,634
Total United Kingdom				3,500,634
United States — 80.9%
Health Care — 78.1%
1Life Healthcare *		161,777		1,805,431
Abbott Laboratories		13,848		1,765,066
ABIOMED *		9,233		2,731,768
Agilent Technologies		14,869		2,071,549
Akoya Biosciences *		201,273		2,286,461
Align Technology *		3,632		1,797,695
Alnylam Pharmaceuticals *		8,101		1,114,698
Arrowhead Pharmaceuticals *		20,560		1,084,746
Avanos Medical *		56,500		1,709,690
Axogen *		290,310		2,528,600
Baxter International		22,584		1,929,577
Becton Dickinson		6,253		1,589,137
BioMarin Pharmaceutical *		22,755		2,016,776
Bio-Rad Laboratories, Cl A *		3,224		1,933,530
Boston Scientific *		70,336		3,017,414
Bristol-Myers Squibb		30,308		1,966,686
Butterfly Network *		416,303		2,414,557
Cardiovascular Systems *		138,839		2,439,401
CareDx *		61,561		2,573,249
Catalent *		20,964		2,178,789
Cerus *		244,517		1,310,611
Charles River Laboratories International *		7,774		2,563,553

ROBO Global^®

Healthcare Technology and Innovation ETF

Schedule of Investments

January 31, 2022 (Unaudited) 

Description	Shares		Fair Value
Codexis *		64,781	$	1,328,011
CONMED		13,054		1,795,969
Danaher		8,649		2,471,798
DexCom *		5,344		2,300,485
Editas Medicine, Cl A *		50,064		953,219
Edwards Lifesciences *		18,806		2,053,615
Exact Sciences *		33,342		2,545,994
Fate Therapeutics *		28,911		1,200,096
Fulgent Genetics *		31,214		1,993,638
Glaukos *		68,920		3,669,302
Globus Medical, Cl A *		23,112		1,542,264
Guardant Health *		28,153		1,958,041
Health Catalyst *		67,069		2,002,010
Hologic *		28,528		2,003,807
Illumina *		8,000		2,790,559
Incyte *		38,816		2,885,192
Insulet *		10,546		2,615,408
Integra LifeSciences Holdings *		44,271		2,866,105
Intuitive Surgical *		8,630		2,452,473
IQVIA Holdings *		9,654		2,364,265
iRhythm Technologies *		27,172		3,391,882
Masimo *		7,369		1,620,222
Medpace Holdings *		10,772		1,911,599
Moderna *		8,328		1,410,180
NanoString Technologies *		56,475		1,960,812
Natera *		32,065		2,265,392
NeoGenomics *		83,744		1,887,590
Nevro *		26,709		1,754,781
Novocure *		33,823		2,321,949
Omnicell *		14,281		2,144,149
Penumbra *		11,193		2,529,730
PerkinElmer		12,501		2,152,297
Quidel *		15,665		1,619,134
Regeneron Pharmaceuticals *		4,026		2,450,183
STAAR Surgical *		31,056		2,258,392
Stryker		8,490		2,105,945
Tabula Rasa HealthCare *		257,422		2,777,583
Tactile Systems Technology *		111,014		1,750,691
Teladoc Health *		30,031		2,303,678
Thermo Fisher Scientific		4,365		2,537,375
Twist Bioscience *		17,106		1,016,439
Veeva Systems, Cl A *		5,565		1,316,345
Veracyte *		76,902		2,338,590
Vertex Pharmaceuticals *		10,215		2,482,756
Vocera Communications *		46,653		3,686,054
				142,614,983
Information Technology — 2.8%
3D Systems *		80,398		1,439,124
Azenta		26,105		2,201,696
Novanta *		9,846		1,359,733
				5,000,553
Total United States				147,615,536
Total Common Stock
(Cost $231,899,328)				182,669,484

Description	Shares		Fair Value
SHORT-TERM INVESTMENT — 0.0%
Invesco Government & Agency, Cl Institutional, 0.03%(A)		71,527	$	71,527
Total Short-Term Investment
(Cost $71,527)				71,527
Total Investments - 100.0%
(Cost $231,970,855)			$	182,741,011

Percentages based on Net Assets of $182,671,597.

*	Non-income producing security.
(A)	Rate shown is the 7-day effective yield as of January 31, 2022.

ADR – American Depository Receipt

Cl – Class

PLC - Public Limited Company

As of January 31, 2022, all of the Fund's investments were considered Level 1 of the fair value hierarchy, in accordance with the authoritative guidance under U.S. GAAP.

For the period ended January 31, 2022, there were no transfers in or out of Level 3.

For information regarding the Trust's policy regarding valuation of investments and other significant accounting policies, please refer to the Trust's most recent semi-annual and annual financial statements.

ROB-QH-001-1700